A Study of Dato-DXd Versus Investigator’s Choice Chemotherapy in Patients with Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02). The gene discussed is CD274; the disease is breast carcinoma.